Ventilatory and P0.1 response to hypercapnia in quadriplegia.
Unlike individuals with comparable degrees of respiratory muscle weakness from other causes, quadriplegic patients have a blunted ventilatory and P0.1 response to hypercapnia. This suggests that the diminished response in quadriplegia is due, in part, to an alteration in respiratory drive. We measured the hypercapnic response in 9 subjects with chronic quadriplegia (Q) and 8 normal controls (N). Ventilatory muscle strength, maximum voluntary ventilation (MVV), and lung volumes were measured in all subjects. The ventilatory response (HCVR) in Q was significantly less than in N (0.73 +/- 0.37 vs 2.95 +/- 0.4 L.min-1.mmHg-1; P less than 0.001), even when normalized for indices of respiratory muscle performance (e.g., vital capacity, MVV). There was no significant change in the HCVR in Q after the administration of naloxone. We also serially studied 2 subjects with acute quadriplegia, and found that despite progressive improvement in respiratory muscle performance, there was no accompanying increase in the response to hypercapnia. These data suggest that muscle weakness alone cannot explain the blunted hypercapnic response in quadriplegia, and are consistent with the hypothesis that these subjects have a reduced ventilatory drive.
Manning
H L
HL
Department of Medicine, Dartmouth Medical School, Hanover, NH.
Brown
R
R
Scharf
S M
SM
Leith
D E
DE
Weiss
J W
JW
Weinberger
S E
SE
Schwartzstein
R M
RM
D000328:Adult; D005652:Functional Residual Capacity / Q000502:physiology; D006801:Humans; D006935:Hypercapnia / Q000150:complications / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009270:Naloxone / Q000494:pharmacology; D011782:Quadriplegia / Q000150:complications / Q000503:physiopathology*; D015656:Respiratory Mechanics / Q000187:drug effects / Q000502:physiology*; D012132:Respiratory Muscles / Q000503:physiopathology
D009270:Naloxone